Search Results | Diabetes | American Diabetes Association

1-20 of 132

2 3 4 5

Sort by

Sort Order Select

Meeting Abstracts

1363-P: Remission of Type 2 Diabetes and Improvement in Incretins, Cardiovascular Risk Factors, and Weight Loss with a High-Protein Diet

FRANKIE B. STENTZ, ANN AMMONS, JOHN V. CHRISTMAN

Diabetes 2022;71(Supplement_1):1363-P

DOI: https://doi.org/10.2337/db22-1363-P

Published: 01 June 2022

View article

Meeting Abstracts

342-OR: Low Incretin Effect Is Associated with Longitudinal Decline of Beta-Cell Function and Insulin Sensitivity in Obese Youth

ALFONSO GALDERISI, JESSICA O. LAT, STEPHANIE SAMUELS, BRIDGET PIERPONT, MICHELLE A. VAN NAME, NICOLA SANTORO, SONIA CAPRIO

Diabetes 2022;71(Supplement_1):342-OR

DOI: https://doi.org/10.2337/db22-342-OR

Published: 01 June 2022

View article

Journal Articles

Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion

Diabetes 2022;71(7):1472–1489

DOI: https://doi.org/10.2337/db21-0800

Published: 26 April 2022

View article

Journal Articles

Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture

Jens Juul Holst

Diabetes 2021;70(11):2468–2475

DOI: https://doi.org/10.2337/dbi21-0026

Published: 22 October 2021

View article

Journal Articles

β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet–Fed Mice

Haopeng Lin, Nancy Smith, Aliya F. Spigelman, Kunimasa Suzuki, Mourad Ferdaoussi, Tamadher A. Alghamdi, Sophie L. Lewandowski, Yaxing Jin, Austin Bautista, Ying Wayne Wang, Jocelyn E. Manning Fox, Matthew J. Merrins, Jean Buteau, Patrick E. MacDonald

Diabetes 2021;70(11):2626–2638

DOI: https://doi.org/10.2337/db20-1235

Published: 30 August 2021

View article

Journal Articles

Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex

Mette Q. Ludwig, Petar V. Todorov, Kristoffer L. Egerod, David P. Olson, Tune H. Pers

Diabetes 2021;70(9):1945–1955

DOI: https://doi.org/10.2337/dbi21-0003

Published: 27 June 2021

View article

Journal Articles

GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Based Therapies in Treating Metabolic Disorders

Ricardo J. Samms, Kyle W. Sloop, Fiona M. Gribble, Frank Reimann, Alice E. Adriaenssens

Diabetes 2021;70(9):1938–1944

DOI: https://doi.org/10.2337/dbi21-0002

Published: 27 June 2021

View article

Meeting Abstracts

224-LB: A Study to Evaluate the Glucagon and Incretin Responses and Identify the Role of Extrapancreatic Glucagon in Patients with Fibrocalcific Pancreatic Diabetes

ANAND SHANKAR

Diabetes 2021;70(Supplement_1):224-LB

DOI: https://doi.org/10.2337/db21-224-LB

Published: 01 June 2021

View article

Meeting Abstracts

38-OR: Deletion of the Mitofusins 1 and 2 (Mfn1 and Mfn2) from the Pancreatic Beta Cell Disrupts Mitochondrial Structure and Impairs Glucose-, but Not Incretin-, Stimulated Insulin Secretion

ELENI GEORGIADOU, CHARANYA MURALIDHARAN, PAULINE L. CHABOSSEAU, ALEJANDRA TOMAS, THEODOROS STYLIANIDES, CRISTINA LEGIDO-QUIGLEY, NOUR ALSABEEH, CÉLINE CRUCIANI-GUGLIELMACCI, CHRISTOPHE MAGNAN, MARK IBBERSON, ISABELLE LECLERC, AMELIA K. LINNEMANN, YUSUF ALI, TRISTAN RODRIGUEZ, GUY A. RUTTER

Diabetes 2021;70(Supplement_1):38-OR

DOI: https://doi.org/10.2337/db21-38-OR

Published: 01 June 2021

View article

Meeting Abstracts

40-OR: Effect of Naturally Occurring Genetic Variations in Incretin Receptors on Glucose Homeostasis

ANIRUDH GAUR

Diabetes 2021;70(Supplement_1):40-OR

DOI: https://doi.org/10.2337/db21-40-OR

Published: 01 June 2021

View article

Meeting Abstracts

1287-PUB: SGK1-NDRG1 Signal Axis as a Key Marker Associated with Insulin Resistance and Impaired Incretin Profile in Subcutaneous and Omental Fat Depots among Obese Patients

IURII STAFEEV, IGOR SKLYANIK, ELIZAVETA MAMONTOVA, SVETLANA MICHURINA, EKATERINA SHESTAKOVA, KAMIL YAHYAEV, ANATOLIY YURASOV, ELIZAVETA RATNER, MIKHAIL MENSHIKOV, ALEXANDER V. VOROTNIKOV, YELENA V. PARFYONOVA, MARINA V. SHESTAKOVA

Diabetes 2021;70(Supplement_1):1287-PUB

DOI: https://doi.org/10.2337/db21-1287-PUB

Published: 01 June 2021

View article

Journal Articles

A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture

Ele Ferrannini

Diabetes 2021;70(2):338–346

DOI: https://doi.org/10.2337/dbi20-0028

Published: 14 January 2021

View article

Journal Articles

Updating the Role of α-Cell Preproglucagon Products on GLP-1 Receptor–Mediated Insulin Secretion

Darleen Sandoval

Diabetes 2020;69(11):2238–2245

DOI: https://doi.org/10.2337/dbi19-0027

Published: 14 October 2020

View article

Journal Articles

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers

Alexander S. Christensen, Sofie Hædersdal, Heidi Storgaard, Kathrine Rose, Nina L. Hansen, Jens J. Holst, Torben Hansen, Filip K. Knop, Tina Vilsbøll

Diabetes 2020;69(9):1989–2002

DOI: https://doi.org/10.2337/db20-0074

Published: 09 June 2020

View article

Meeting Abstracts

324-OR: The Incretin Action of GIP Is Mediated through Both Alpha and Beta Cells

KIMBERLEY M. EL, MEGAN CAPOZZI, SARAH M. GRAY, JENNIFER L. BROWN, FRANCIS S. WILLARD, PAUL EMMERSON, KYLE SLOOP, DAVID D’ALESSIO, JONATHAN CAMPBELL

Diabetes 2020;69(Supplement_1):324-OR

DOI: https://doi.org/10.2337/db20-324-OR

Published: 01 June 2020

View article

Meeting Abstracts

61-OR: Genetic and Metabolic Determinants of the Incretin Effect in Obese Adolescent with Prediabetes

ALFONSO GALDERISI, STEPHANIE SAMUELS, BRIDGET PIERPONT, CHIARA DALLA MAN, NICOLA SANTORO, SONIA CAPRIO

Diabetes 2020;69(Supplement_1):61-OR

DOI: https://doi.org/10.2337/db20-61-OR

Published: 01 June 2020

View article

Meeting Abstracts

2140-PUB: Effect of Metformin on Incretin Secretion in Patients with Diabetes and Chronic Heart Failure

JAN KOPECKY, JR., EVA HOŠKOVÁ, JIRI VELEBA, VOJTECH MELENOVSKY, TEREZIE PELIKANOVA

Diabetes 2020;69(Supplement_1):2140-PUB

DOI: https://doi.org/10.2337/db20-2140-PUB

Published: 01 June 2020

View article

Meeting Abstracts

2313-PUB: Alterations in Basal State of Insulin and mTOR-Dependent Signalings Closely Related to Impaired Incretin Profile and Type 2 Diabetes in Subcutaneous Adipose Tissue of Obese Patients

IURII STAFEEV, IGOR SKLYANIK, SVETLANA MICHURINA, EKATERINA SHESTAKOVA, ANATOLIY YURASOV, KAMIL YAHYAEV, ANDREY KARMADONOV, ELIZAVETA RATNER, MIKHAIL MENSHIKOV, ALEXANDER V. VOROTNIKOV, YELENA V. PARFYONOVA, MARINA V. SHESTAKOVA

Diabetes 2020;69(Supplement_1):2313-PUB

DOI: https://doi.org/10.2337/db20-2313-PUB

Published: 01 June 2020

View article

Meeting Abstracts

78-OR: Glycaemia, Beta-Cell Function, and Incretin Hormones Post-OGTT One Year after Gastric Bypass and Sleeve Gastrectomy in Patients with Morbid Obesity and Type 2 Diabetes: An RCT (Oseberg Study)

FARHAT FATIMA, JØRAN HJELMESÆTH, KARE I. BIRKELAND, HANNE L. GULSETH, JENS K. HERTEL, MARIUS SVANEVIK, RUNE SANDBU, BOLETTE HARTMANN, JENS J. HOLST, DAG HOFSØ

Diabetes 2020;69(Supplement_1):78-OR

DOI: https://doi.org/10.2337/db20-78-OR

Published: 01 June 2020

View article

Meeting Abstracts

141-OR: Efficacy and Safety of Naltrexone/Bupropion as Add-On to Incretin Agents in Patients with Obesity and T2DM

SEAN WHARTON, PETER YIN, FERNANDO CAMACHO, MELONIE BURROWS, JESSICA BLAVIGNAC, MAXIME BARAKAT

Diabetes 2020;69(Supplement_1):141-OR

DOI: https://doi.org/10.2337/db20-141-OR

Published: 01 June 2020

View article

2 3 4 5

NARROW

1363-P: Remission of Type 2 Diabetes and Improvement in Incretins, Cardiovascular Risk Factors, and Weight Loss with a High-Protein Diet

342-OR: Low Incretin Effect Is Associated with Longitudinal Decline of Beta-Cell Function and Insulin Sensitivity in Obese Youth

Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion

Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture

β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet–Fed Mice

Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex

GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Based Therapies in Treating Metabolic Disorders

224-LB: A Study to Evaluate the Glucagon and Incretin Responses and Identify the Role of Extrapancreatic Glucagon in Patients with Fibrocalcific Pancreatic Diabetes

38-OR: Deletion of the Mitofusins 1 and 2 (Mfn1 and Mfn2) from the Pancreatic Beta Cell Disrupts Mitochondrial Structure and Impairs Glucose-, but Not Incretin-, Stimulated Insulin Secretion

40-OR: Effect of Naturally Occurring Genetic Variations in Incretin Receptors on Glucose Homeostasis

1287-PUB: SGK1-NDRG1 Signal Axis as a Key Marker Associated with Insulin Resistance and Impaired Incretin Profile in Subcutaneous and Omental Fat Depots among Obese Patients

A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture

Updating the Role of α-Cell Preproglucagon Products on GLP-1 Receptor–Mediated Insulin Secretion

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers

324-OR: The Incretin Action of GIP Is Mediated through Both Alpha and Beta Cells

61-OR: Genetic and Metabolic Determinants of the Incretin Effect in Obese Adolescent with Prediabetes

2140-PUB: Effect of Metformin on Incretin Secretion in Patients with Diabetes and Chronic Heart Failure

2313-PUB: Alterations in Basal State of Insulin and mTOR-Dependent Signalings Closely Related to Impaired Incretin Profile and Type 2 Diabetes in Subcutaneous Adipose Tissue of Obese Patients

78-OR: Glycaemia, Beta-Cell Function, and Incretin Hormones Post-OGTT One Year after Gastric Bypass and Sleeve Gastrectomy in Patients with Morbid Obesity and Type 2 Diabetes: An RCT (Oseberg Study)

141-OR: Efficacy and Safety of Naltrexone/Bupropion as Add-On to Incretin Agents in Patients with Obesity and T2DM

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only